Meta-analysis: Polymorphisms in TNF-α gene promoter and Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 2, 2010, Pages 159-170

  Han, Z ^a   Li, C ^a   Han, S ^a   Han, Y ^a   Qiu, J ^a   Shi, Y ^a   Wang, J ^a   Sun, A ^a   Ding, J ^a   Wu, K ^a   Fan, D ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CROHN DISEASE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SYSTEMATIC REVIEW; TNF ALPHA GENE;

CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NECROSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953801700     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04340.x     Document Type: Article

References (45)

1. Wall GC, Heyneman C, Pfanner TP. Medical options for treating Crohn's disease in adults: focus on antitumor necrosis factor-alpha chimeric monoclonal antibody. Pharmacotherapy 1999 19 : 1138 1152.
2. Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 1999 5 : 119 133.
3. Yang SK, Lee SG, Cho YK, et al. Association of TNF-alpha/LTA polymorphisms with Crohn's disease in Koreans. Cytokine 2006 35 : 13 20.
4. Negoro K, Kinouchi Y, Hiwatashi N, et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999 117 : 1062 1068.
5. Meijer MJ, Mieremet-Ooms MA, van Duijn W, et al. Effect of the anti-tumor necrosis factor-alpha antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel disease. Inflamm Bowel Dis 2007 13 : 200 210.
6. Cucchiara S, Latiano A, Palmieri O, et al. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007 44 : 171 179.
7. Kozaiwa K, Sugawara K, Smith MF Jr., et al. Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Gastroenterology 2003 125 : 477 490.
8. van Heel DA, Udalova IA, De Silva AP, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 2002 11 : 1281 1289.
9. Guerreiro CS, Ferreira P, Tavares L, et al. Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease. Am J Gastroentero 2009 104 : 2241 2249.
10. Ferguson LR, Huebner C, Petermann I, et al. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroentero 2008 14 : 4652 4661.
11. Hong J, Leung E, Fraser AG, Merriman TR, Vishnu P, Krissansen GW. IL4, IL10, IL16, and TNF polymorphisms in New Zealand Caucasian Crohn's disease patients. Int J Colorectal Dis 2008 23 : 335 337.
12. Hradsky O, Lenicek M, Dusatkova P, et al. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs. Tissue Antigens 2008 71 : 538 547.
13. Mittal RD, Manchanda PK, Bid HK, Ghoshal UC. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India. J Gastroenterol Hepatol 2007 22 : 920 924.
14. Sykora J, Subrt I, Didek P, et al. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G - >A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 2006 42 : 479 487.
15. Dalal I, Karban A, Wine E, et al. Polymorphisms in the TNF-alpha promoter and variability in the granulomatous response in patients with Crohn's disease. Pediatr Res 2006 59 : 825 828.
16. Celik Y, Dagli U, Kilic MY, et al. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand J Gastroenterol 2006 41 : 559 565.
17. Fidder HH, Heijmans R, Chowers Y, et al. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease. Int J Immunogenet 2006 33 : 81 5.
18. Castro-Santos P, Suarez A, Lopez-Rivas L, et al. TNF alpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Am J Gastroenterol 2006 101 : 1039 1047.
19. Tremelling M, Waller S, Bredin F, et al. Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort. Inflamm Bowel Dis 2006 12 : 178 184.
20. Song Y, Wu KC, Zhang L, et al. Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease. Chin J Dig Dis 2005 6 : 170 174.
21. Fowler EV, Eri R, Hume G, et al. TNF alpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J Med Genet 2005 42 : 523 528.
22. Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005 100 : 1134 1142.
23. Ferreira AC, Almeida S, Tavares M, et al. NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflamm Bowel Dis 2005 11 : 331 339.
24. Levine A, Karban A, Eliakim R, et al. A polymorphism in the TNF-alpha promoter gene is associated with pediatric onset and colonic location of Crohn's disease. Am J Gastroenterol 2005 100 : 407 413.
25. Zipperlen K, Peddle L, Melay B, et al. Association of TNF-alpha polymorphisms in Crohn disease. Hum Immunol 2005 66 : 56 9.
26. Balding J, Livingstone WJ, Conroy J, et al. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm 2004 13 : 181 187.
27. Vatay A, Bene L, Kovacs A, et al. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 2003 55 : 247 252.
28. Gonzalez S, Rodrigo L, Martinez-Borra J, et al. TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 2003 98 : 1101 1106.
29. Martin K, Radlmayr M, Borchers R, et al. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 2002 66 : 121 126.
30. Sashio H, Tamura K, Ito R, et al. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002 53 : 1020 1027.
31. Louis E, Peeters M, Franchimont D, et al. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol 2000 119 : 64 8.
32. Hirv K, Seyfarth M, Uibo R, et al. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers. Scand J Gastroenterol 1999 34 : 1025 1032.
33. Louis E, Satsangi J, Roussomoustakaki M, et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996 39 : 705 710. (Pubitemid 26426472)
34. Bouma G, Xia B, Crusius JB, et al. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1996 103 : 391 396.
35. Petitti D. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis.
36. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997 127 : 820 826.
37. Lau J, Antman E M, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992 327 : 248 254.
38. Bouma G, Poen AC, Garcia-Gonzalez MA, et al. HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics 1998 47 : 451 455.
39. Hohjoh H, Tokunaga K. Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun 2001 2 : 105 109.
40. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997 94 : 3195 3199.
41. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008 40 : 955 962.
42. Kugathasan S, Baldassano RN, Bradfield JP, et al. TNFRSF6B mRNA expression correlated with the degree of mucosal inflammation within the colon Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 2008 40 : 1211 1215.
43. Dubinsky MC, Mei L, Friedman M, et al. Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2010 [Epub ahead of print].
44. Chua KH, Hilmi I, Ng CC, et al. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease. J Dig Dis 2009 10 : 124 130.
45. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998 51 : 605 612.